Sanofi
corporate_fare Company Profile
Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek monitors SNY SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Sanofi Reports Positive Phase 2 Lunsekimig Data and EU Approval for Dupixent in Young Children with CSU
- Sanofi's Lunsekimig Meets Phase 2 Endpoints in Asthma and CRSwNP, Bolstering Respiratory Pipeline
- Sanofi Reports Positive Phase 3 Amlitelimab Data for Atopic Dermatitis, Advances Pipeline
- Sanofi's Rezurock Secures EU Conditional Approval for Chronic Graft-vs-Host Disease
- CHMP Recommends EU Approval for Sanofi's Innovative Sarclisa On-Body Injector for Multiple Myeloma
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
$7.85B
Diluted EPS
$6.37
Op. Cash Flow
$10.75B
Free Cash Flow
$7.21B
Gross Profit
$33.67B
Operating Income
$6.34B
Cash & Equivalents
$877M
Total Debt
$14.25B
Debt / Equity
0.20×
Shares Outstanding
1.22B sh
Source: 20-F · filed 2026-02-17 · accession 0001628280-26-008403
Insider Transactions
SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed SNY - Filings & News (Page 2)
SNY
Apr 15, 2026, 6:57 AM EDT
Price at Filing:
$48.24
Real-time Price:
$45.20
Change:
-$3.04 (-6%)
Market Cap:
$106.869B
SNY
Apr 07, 2026, 1:00 AM EDT
Price at Filing:
$47.74
Real-time Price:
$45.20
Change:
-$2.54 (-5%)
Market Cap:
$106.869B
SNY
Mar 31, 2026, 12:19 PM EDT
Price at Filing:
$47.55
Real-time Price:
$45.20
Change:
-$2.35 (-5%)
Market Cap:
$106.869B
SNY
Mar 31, 2026, 1:00 AM EDT
Price at Filing:
$46.60
Real-time Price:
$45.20
Change:
-$1.40 (-3%)
Market Cap:
$106.869B
SNY
Mar 27, 2026, 8:00 AM EDT
Price at Filing:
$47.37
Real-time Price:
$45.20
Change:
-$2.17 (-5%)
Market Cap:
$106.869B
SNY
Mar 18, 2026, 2:00 AM EDT
Price at Filing:
$44.07
Real-time Price:
$45.20
Change:
+$1.13 (+3%)
Market Cap:
$106.869B
SNY
Mar 03, 2026, 6:15 AM EST
Price at Filing:
$46.50
Real-time Price:
$45.20
Change:
-$1.30 (-3%)
Market Cap:
$106.869B
SNY
Feb 23, 2026, 9:19 AM EST
Price at Filing:
$47.12
Real-time Price:
$45.20
Change:
-$1.92 (-4%)
Market Cap:
$106.869B
SNY
Feb 17, 2026, 12:34 PM EST
Price at Filing:
$46.31
Real-time Price:
$45.20
Change:
-$1.11 (-2%)
Market Cap:
$106.869B
SNY
Feb 17, 2026, 9:33 AM EST
Price at Filing:
$46.29
Real-time Price:
$45.20
Change:
-$1.08 (-2%)
Market Cap:
$106.869B
SNY
Feb 12, 2026, 9:17 AM EST
Price at Filing:
$46.91
Real-time Price:
$45.20
Change:
-$1.71 (-4%)
Market Cap:
$106.869B
SNY
Feb 10, 2026, 9:18 AM EST
Price at Filing:
$48.66
Real-time Price:
$45.20
Change:
-$3.46 (-7%)
Market Cap:
$106.869B
SNY
Feb 10, 2026, 6:06 AM EST
Price at Filing:
$48.65
Real-time Price:
$45.20
Change:
-$3.45 (-7%)
Market Cap:
$106.869B
SNY
Feb 06, 2026, 10:09 AM EST
Price at Filing:
$47.37
Real-time Price:
$45.20
Change:
-$2.17 (-5%)
Market Cap:
$106.869B
SNY
Jan 30, 2026, 7:55 AM EST
Price at Filing:
$46.58
Real-time Price:
$45.20
Change:
-$1.38 (-3%)
Market Cap:
$106.869B
SNY
Jan 29, 2026, 8:56 AM EST
Price at Filing:
$46.52
Real-time Price:
$45.20
Change:
-$1.32 (-3%)
Market Cap:
$106.869B
SNY
Jan 28, 2026, 6:37 AM EST
Price at Filing:
$46.64
Real-time Price:
$45.20
Change:
-$1.44 (-3%)
Market Cap:
$106.869B
SNY
Jan 23, 2026, 9:58 AM EST
Amlitelimab Phase 3 Studies Show Mixed Results in Atopic Dermatitis, Sanofi Plans Global Submissions
Price at Filing:
$46.42
Real-time Price:
$45.20
Change:
-$1.22 (-3%)
Market Cap:
$106.869B
SNY
Jan 16, 2026, 6:02 AM EST
Price at Filing:
$45.52
Real-time Price:
$45.20
Change:
-$0.320 (-0.70%)
Market Cap:
$106.869B
SNY
Jan 12, 2026, 6:11 AM EST
Price at Filing:
$49.43
Real-time Price:
$45.20
Change:
-$4.23 (-9%)
Market Cap:
$106.869B